1. alfrecollin0
2. swirv
1.swirv 06/13/2018
Aytu BioScience Enters $1.8 Billion U.S. Prescription Sleep Aid Market with Exclusive License to Zolpimist(TM) to Expand Company's Commercial-Stage Product Portfolio
2.swirv 03/09/2018
Aytu BioScience Receives Market Registration for the MiOXSYS® System for Male Infertility in Mexico
3.alfrecollin0 03/01/2018
Aytu BioScience Announces Pricing of $12,000,000 Public Offering
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW